Navigation Links
UAS Laboratories Enters Into Agreement to Launch New Probiotic Product at Expo West
Date:12/29/2010

EDEN Prairie, Minn., Dec. 29, 2010 /PRNewswire/ -- UAS Laboratories, Inc. entered into an agreement with Valensa and Parry Nutraceuticals to launch Probiogreen™, a new product combining premium DDS Probiotics with Parry organic spirulina. Tests with spirulina and Lactobacillus showed that spirulina can stimulate the growth of Lactobacillus.  Probiogreen™ will be available as a finished product or as a raw material. Possible applications include, supplement powders, smoothie mixes, beverages, and supplements.  The recommended dose is contained in 1/4 teaspoon (1 gm).  Many green formula products use up to 4 teaspoons of ingredients.  

Parry spirulina has received GRAS status for its Arthrospira platensis which is produced in accordance with cGMP and is certified organic by USDA NOP, Naturland-Germany, Ecocert-France, OCIA-IFOAM standards.  Spriulina, a microscopic aquatic organism, has a long history of human consumption. The health benefits are widely researched and show promise in many age-related health conditions like age-related macular degeneration (ARMD), type 2 diabetes, non-alcoholic fatty liver disease, neurodegenerative disorders and cardiovascular disease.  

DDS® Probiotics, produced by UAS Laboratories, Inc., have been used by millions of consumers around the world since 1979.  The Lactobacillus acidophilus DDS®-1 strain, that is the foundation of all UAS Labs probiotic blends, has over 200 university and clinical studies that demonstrate its efficacy in a wide range of health conditions.  

About UAS Laboratories, Inc.

UAS Laboratories, Inc. (Eden Prairie, MN USA), established in 1979, is one of the world's leading biotechnology companies specializing in research, manufacture and marketing of probiotics for human health.  The company produces products containing the trademarked, patented, superstrain, Lactobacillus acidophilus DDS®-1, a probiotic with over 200 university and clinical studies.  DDS® Probiotics are sold to natural products retailers, health professionals, private label customers and as ingredients to manufacturers in the US, Canada and over 35 other countries.  UAS Labs was founded by Dr. S.K. Dash, the probiotic pioneer.  Dr. Dash is the Vice President and Scientific Advisor of the International Probiotic Association and Adjunct Professor of Nutrition and Food Science at South Dakota State University.  

For more information, contact Dr. S.K. Dash, directly, at dash@uaslabs.com. 952-935-1707.  www.uaslabs.com.


'/>"/>
SOURCE UAS Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. AIT Laboratories Expands Pharma Services
2. Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger
3. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 Second Quarter Earnings
4. Core Laboratories Joint Venture Agreement Between genae associates, VIBGYOR Scientific Research, Cardiovascular Center Aalst and J.B. Dahm
5. Clontech Laboratories, Inc. Recognizes the 2008 Winners of the Nobel Prize in Chemistry
6. Caraco Pharmaceutical Laboratories Ltd. to Announce Second Quarter of Fiscal Year 2009 Results on October 23, 2008
7. Phenomix and Forest Laboratories to Collaborate on Development and Commercialization of Dutogliptin in Diabetes
8. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal 2009
9. Romark Laboratories Announces Presentation of New Nitazoxanide Data at 59th Annual AASLD Meeting and 50th Anniversary IASL Meeting in San Francisco
10. Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD)
11. Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... Scientists propose in Nature blocking ... Gaucher and maybe other lysosomal storage diseases as a ... current therapies. An international research team led ... also included investigators from the University of Lübeck in ... 22. The study was conducted in mouse models of ...
(Date:2/22/2017)... Yorba Linda, Ca (PRWEB) , ... February 22, ... ... interactive virtual events for tech innovators, engineers, and scientists from around the world, ... event will place on February 22 and 23, 2017. This premier, online-only conference ...
(Date:2/22/2017)... , Feb. 22, 2017 Origin (Origin Agritech, LLC, a ... and seed provider, and Arcadia (Arcadia Biosciences, ... develops and commercializes agricultural productivity traits and nutritional products, today announced ... biotechnology product developed in China to ... trials. ...
(Date:2/22/2017)... ... February 22, 2017 , ... Pharma and biotech consulting ... European director. Operating from Pennside’s Zurich headquarters, Pennside Partners, GmbH, Mr. Perkins brings ... after more than a decade with leading market research firm, GfK. He began ...
Breaking Biology Technology:
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... The global synthetic-biology market ... billion by 2021, growing at a compound annual growth rate ... overview of the global markets for synthetic biology. - Analyses ... 2016, and projections of compound annual growth rates (CAGRs) through ...
(Date:2/7/2017)... 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... will present at the LEERINK Partners 6th Annual Global ... on Wednesday, February 15, 2017 at 10 a.m. Eastern ... presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  The ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
Breaking Biology News(10 mins):